Urolithiasis pp 619-622 | Cite as

Urinary Glycosaminoglycan Excretion in Patients with Urolithiasis

  • John D. Sallis
  • K.-H. Bichler
  • S. Korn
  • A. Haußmann


Present evidence based on the physicochemical properties and distribution of glycosaminoglycans suggest that these compounds may play an important role in urolithiasis. Although the organic matrix of stones is not known to contain appreciable amounts of glycosaminoglycans1, it has been suggested that glycosaminoglycans and, in particular, the degree of sulphation of the molecules, may be a regulating factor in the initiation or development of calculi2. Both natural and commercially prepared glycosaminoglycans in vitro have been shown to be powerful inhibitors of calcium oxalate crystal formation and growth3,4.Urine contains several types of glycosaminoglycans, the predominant class being chondroitin sulphates A and C. Undoubtedly, the so called inhibitory power of urine is to some degree associated with these polyanionic substances4. The true potential of the compounds however, may be subject to modification by some other urinary components, for example, urates5.


Uronic Acid Ureter Stone Stone Material Excretion Pattern Predominant Class 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    W. H. Boyce and F. K. Garvey, J. Urol. 76:213 (1956).PubMedGoogle Scholar
  2. 2.
    W. O. Foye, H. S. Hong, C. M. Kim, and E. L. Prien, Sr., Invest. Urol. 14:33 (1976).PubMedGoogle Scholar
  3. 3.
    W. G. Robertson, M. Peacock, and B. E. C. Nordin, Clin. Chim. Acta. 43:31 (1973).PubMedCrossRefGoogle Scholar
  4. 4.
    J. D. Sallis and M. E. Lumley, Invest. Urol. 16:296 (1979).PubMedGoogle Scholar
  5. 5.
    W. G. Robertson, M. Peacock, P. J. Heyburn, D. H. Marshall, and P. B. Clark. Br. J. Urol. 50:449 (1978).PubMedCrossRefGoogle Scholar
  6. 6.
    D. Kaplan, Am. J. Med. 47:721 (1969).PubMedCrossRefGoogle Scholar
  7. 7.
    P. C. Hallson and G. A. Rose, Clin. Chim. Acta. 52:29 (1974).CrossRefGoogle Scholar
  8. 8.
    K.-H. Bichler, H. Haupt, G. Uhlemann, and H. G. Schwick, Urol. Res. 1:50 (1973).PubMedCrossRefGoogle Scholar
  9. 9.
    A. Knappwost and S. Gerlach, in: “Pathogenese und Klinik der Harnsteine,” V. G. Gasser and W. Vahlensieck, eds., D. Steinkoff-Verlag, Darmstadt (1977).Google Scholar
  10. 10.
    N. Blumenkrantz and G. Asboe-Hansen, Anal. Biochem. 54:484 (1973).PubMedCrossRefGoogle Scholar
  11. 11.
    K.-H. Bichler, C. Kirchner, and V. Ideler, Br. J. Urol. 47:733 (1976).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • John D. Sallis
    • 1
  • K.-H. Bichler
    • 2
  • S. Korn
    • 2
  • A. Haußmann
    • 2
  1. 1.Department of BiochemistryUniversity of TasmaniaAustralia
  2. 2.Department of UrologyUniversity of TubingenWest Germany

Personalised recommendations